CER To Play A Larger Role In Investment Decisions – Merck's McElwee

Pharmaceutical companies are going to need to consider the impact of the growing emphasis on comparative effectiveness earlier in the drug development and investment decision process, Merck & Co.'s Newell McElwee said.